JAMES WILLIAM LEWIS

Allopathic & Osteopathic Physicians|Internal Medicine PHILADELPHIA, PA NPI 1700979986

General Payments — all program years on this page

$105,863.79

  • Category: General Payments
  • Program years: PY2018–2022
  • Record count: 15
  • As of (CMS publication): 2026-01-23

Latest program year (PY2022): $105,829.36 across 13 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2022) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $105,829.3613

By paying entity

Latest program year (PY2022) · sorted by reported total.

Paying entityAmountRecords
INTERCEPT PHARMACEUTICALS, INC. $105,829.3613

By program year

Program yearAmountRecords
2018 $34.432
2022 $105,829.3613

Records — PY2022 (13)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
957885745 Intercept Pharmaceuticals, Inc. $4,333.16 06/27/2022 Consulting Fee Undisputed 01/23/2026 View at CMS
957885749 Intercept Pharmaceuticals, Inc. $2,833.22 06/02/2022 Consulting Fee Undisputed 01/23/2026 View at CMS
957885753 Intercept Pharmaceuticals, Inc. $7,666.36 01/18/2022 Consulting Fee Undisputed 01/23/2026 View at CMS
957885757 Intercept Pharmaceuticals, Inc. $17,832.74 03/14/2022 Consulting Fee Undisputed 01/23/2026 View at CMS
957885761 Intercept Pharmaceuticals, Inc. $28,332.20 02/11/2022 Consulting Fee Undisputed 01/23/2026 View at CMS
957885765 Intercept Pharmaceuticals, Inc. $4,999.82 04/22/2022 Consulting Fee Undisputed 01/23/2026 View at CMS
957885769 Intercept Pharmaceuticals, Inc. $13,332.88 12/05/2022 Consulting Fee Undisputed 01/23/2026 View at CMS
957885775 Intercept Pharmaceuticals, Inc. $4,499.84 11/21/2022 Consulting Fee Undisputed 01/23/2026 View at CMS
957885779 Intercept Pharmaceuticals, Inc. $4,333.16 08/29/2022 Consulting Fee Undisputed 01/23/2026 View at CMS
957885783 Intercept Pharmaceuticals, Inc. $2,833.24 10/03/2022 Consulting Fee Undisputed 01/23/2026 View at CMS
957885787 Intercept Pharmaceuticals, Inc. $1,999.92 12/12/2022 Consulting Fee Undisputed 01/23/2026 View at CMS
957885791 Intercept Pharmaceuticals, Inc. $4,833.14 05/23/2022 Consulting Fee Undisputed 01/23/2026 View at CMS
957885797 Intercept Pharmaceuticals, Inc. $7,999.68 08/02/2022 Consulting Fee Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.